France, Italy, Belgium act to stop use of hydroxychloroquine for COVID-19 on safety fears
Merck CEO Casts Doubt On ‘Very Aggressive’ Covid-19 Vaccine Timeline
UK okays early access to Gilead’s remdesivir in seriously ill COVID-19 patients
Merck & Co and IAVI join forces to develop COVID-19 vaccine
Promising pre-clinical results for USask VIDO-InterVac COVID-19 vaccine
Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2
Merck Takes 3 Major Shots at COVID-19
Some patients with bladder cancer ‘can’t wait’ for treatment during the COVID-19 pandemic
3 "Strong Buy" Biotech Stocks Under $5 With Massive Upside Potential
Airway Therapeutics, Celonic Group partner to produce AT-100 as candidate for coronavirus
Gilead Still Holds the Winning Hand, Says 5-Star Analyst
Inovio Pops Almost 10% on ‘Positive’ Preclinical Results For Its Covid-19 Vaccine
Prellis Bio’s Externalized Human Immune System rapidly generates 300 SARS-CoV2 antibodies
Moderna stock volatile amid work on coronavirus vaccine
Statistical approach to COVID-19 clinical trials aims to accelerate drug approval process
COVID-19 prevention trial opens for high-risk healthcare workers
Dynavax Explodes 40% In Pre-Market On Phase 1 Covid-19 Vaccine News
X-ray experiments zero in on COVID-19 antibodies
Global study to test malaria drug to protect health workers from COVID-19
Covid-19 roundup: Kate Bingham to lead UK taskforce; Federal judge to Shkreli: You’re not going to save the world, stay in prison
‘Like looking for a needle in a haystack’: the global hunt to block COVID-19
AstraZeneca Aiming For 30M UK Covid-19 Vaccine Doses By September
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
Using telehealth to transition diabetes inpatients to virtual care during COVID-19
UHN-U of T-led study shows antiviral drug can speed up recovery of COVID-19 patient
Analyst Places a Long-Shot Bet on Pluristem (PSTI) Stock
Applied DNA Sciences Tackles COVID-19 on Three Fronts; Analyst Says 'Buy'
Novavax (NVAX): Next Stop, $150?
New study to assess the efficacy of ivermectin against COVID-19
Skilled partners in the conduct of HIV prevention trials join COVID-19 response